Myopia Control Soft Contact Lenses, Children, 2 Years
Summary
A clinical trial registration (NCT07547085) has been published on ClinicalTrials.gov for a study investigating myopic control efficacy of novel soft contact lenses in children. The study will enroll participants prescribed either Lens A, Lens B, or single vision contact lenses for the first year, with single vision wearers switching to Lens A at 12 months. All participants will continue lens wear for an additional 12 months, with cycloplegic refraction and axial length monitored every 6 months over the 2-year study period. The study is registered under Condition: Myopia.
“Participants will be prescribed Lens A, Lens B or single vision contact lenses for the first year.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
The study registration describes a randomized clinical trial design comparing two investigational soft contact lenses (Lens A and Lens B) against single vision contact lenses for myopia control in children aged approximately 5-12 years. Participants in the single vision group will cross over to Lens A at the 12-month timepoint. The primary endpoints are cycloplegic refraction and axial length, measured every 6 months across the 24-month study duration. Investigators, ethics committees, and sponsors involved in pediatric ophthalmology or myopia management research should be aware of this upcoming evidence on novel contact lens interventions for myopia progression control.
Affected parties include pediatric eye care researchers, contact lens manufacturers developing myopia control products, institutional review boards reviewing pediatric device studies, and ophthalmology practices seeking evidence-based myopia management options for patients.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Myopia Control Using Novel Soft Contact Lenses
N/A NCT07547085 Kind: NA Apr 23, 2026
Abstract
The goal of this study is to investigate the myopic control efficacy of two study soft contact lenses in children. Participants will be prescribed Lens A, Lens B or single vision contact lenses for the first year. Participants in single vision contact lenses group will switch to Lens A at 12 months. All participants will then continue lens wear for an additional 12 months. Their cycloplegic refraction and axial length will be monitored every 6 months for 2 years.
Conditions: Myopia
Interventions: Lens A, Lens B
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.